Acknowledgement
We thank professor Alexander Averyanov, Evgeny Ilyushnikov, Dmitry Panchenkov and Bychinin Mikhail for their help in organizing of the study.
References
- Thiberville L, Salaun M, Lachkar S, Dominique S, Moreno-Swirc S, Vever-Bizet C, et al. Human in vivo fluorescence microimaging of the alveolar ducts and sacs during bronchoscopy. Eur Respir J 2009;33:974-85. https://doi.org/10.1183/09031936.00083708
- Salaun M, Roussel F, Hauss PA, Lachkar S, Thiberville L. In vivo imaging of pulmonary alveolar proteinosis using confocal endomicroscopy. Eur Respir J 2010;36:451-3. https://doi.org/10.1183/09031936.00194509
- Lesur O, Chagnon F, Lebel R, Lepage M. In vivo endomicroscopy of lung injury and repair in ARDS: potential added value to current imaging. J Clin Med 2019;8:1197. https://doi.org/10.3390/jcm8081197
- Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020;46:586-90. https://doi.org/10.1007/s00134-020-05985-9
- Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, et al. Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol 2021;288:103645. https://doi.org/10.1016/j.resp.2021.103645
- Heching M, Lev S, Shitenberg D, Dicker D, Kramer MR. Surfactant for the treatment of ARDS in a patient with COVID-19. Chest 2021;160:e9-12. https://doi.org/10.1016/j.chest.2021.01.028
- Busani S, Dall'Ara L, Tonelli R, Clini E, Munari E, Venturelli S, et al. Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. Ther Adv Respir Dis 2020;14:1753466620951043.